CLOSTRIDIUM PERFRINGENS BETA-TOXIN: CHARACTERIZATION AND ACTION

References

• Costa S. K. P., De Nucci G., Antunes E., Brain S. D. Involvement of vanilloid receptors and purinoceptors in the Phoneutria nigriventer spider venom-induced plasma extravasation in rat skin. Eur. J. Pharmacol. 2000; 391(3)305–315, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Davis M., Lawrence G., Shann F., Walker P. D. Longevity of protection by active immunisation against necrotising enteritis in Papua New Guinea. Lancet 1982; 320(8294)389–390, [CROSSREF], [CSA]
   Google Scholar
• Friedrichson T., Kurzchalia T. V. Microdomains of GPI-anchored proteins in living cells revealed by crosslinking. Nature 1998; 394(6695)802–805, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Gibert M., Jolivet-Reynaud C., Popoff M. R. Beta2 toxin, a novel toxin produced by Clostridium perfringens. Gene. 1997; 203(1)65–73, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gordon V. M., Nelson K. L., Buckley J. T., Stevens V. L., Tweten R. K., Elwood P. C., Leppla S. H. Clostridium septicum alpha toxin uses glycosylphosphatidylinositol-anchored protein receptors. J. Biol. Chem. 1999; 274(38)27274–27280, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. Gen. Pharmacol. 1998; 30(1)5–11, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Hunter S. E. C., Brown J. E., Oyston P. C. F., Sakurai J., Titball R. W. Molecular genetic analysis of beta-toxin of Clostridium perfringens reveals sequence homology with alpha-toxin, gamma-toxin, and leukocidin of Staphylococcus aureus. Infect. Immun., 61(9)3958–3965, [CSA]
   Google Scholar
• Johnson E. M., O'Brien F. Evaluation of the permanent sympathectomy produced by the administration of guanethidine to adult rats. J. Pharmacol. Exp. Ther. 1976; 196(1)53–61, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Johnson S., Taylor D. N., Coninx R., Eampokalap B., Cooke R. A., Echeverria P., Paul S. R., Sakurai J., Jimakorn P., Lawrence G. W., Walker P. D. Enteritis necroticans among Khmer children at an evacuation site in Thailand. Lancet 1987; 330(8557)496–500, [CROSSREF], [CSA]
   Google Scholar
• Kilsdonk E. P. C., Yancey P. G., Stoudt G. W., Bangerter F. W., Johnson W. J., Phillips M. C., Rothbalt G. H. Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem. 1995; 270(29)17250–17256, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kennedy K. K., Norris S. J., Beckenhauer W. H., White R. G. Vaccination of cattle and sheep with a combined Clostridium perfringens types C and D toxoid. Am. J. Vet. Res. 1977; 38(10)1515–1517, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Kvetnansky R., Weise V. K., Thoa N. B., Kopin I. J. Effects of chronic guanethidine treatment and adrenal medullectomy on plasma levels of catecholamines and corticosterone in forcibly immobilized rats. J. Pharmacol. Exp. Ther. 1979; 209(2)287–291, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Lawrence G., Shann F., Freestone D. S., Walker P. D. Prevention of necrotising enteritis in Papua New Guinea by active immunisation. Lancet 1979; 313(8110)227–230, [CROSSREF], [CSA]
   Google Scholar
• McDonel J. L. Toxins of Clostridium perfringens types A, B, C, D and E. Pharmacology of Bacterial Toxin, F. Dorner, J. Drews. Pergamon Press, Oxford 1986; 477–517
   Google Scholar
• Mitchell T. J., Andrew P. W., Saunders F. K., Smith A. N., Boulnois G. J. Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol. Microbiol. 1991; 5(8)1883–1888, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Miyata S., Minami J., Tamai E., Matsushita O., Shimamoto S., Okabe A. Clostridium perfringens epsilon-toxin forms a heptameric pore within the detergent-insoluble microdomains of Madin-Darby canine kidney cells and Rat Synaptosomes. J. Biol. Chem. 2002; 277(42)39463–39468, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Murrell T. G. C., Roth L. Necrotizing jejunitis: a newly discovered disease in highlands of New Guinea. Med. J. Australia 1963; 50(1)61–69, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Murrell T. G. C., Roth L., Egerton J., Samels J., Walker P. D. Pig-bel: enteritis necroticans: a study in diagnosis and management. Lancet 1966; 287(7431)217–222, [CROSSREF], [CSA]
   Google Scholar
• Nagahama M., Kihara A., Miyawaki T., Mukai M., Sakaguchi Y., Ochi S., Sakurai J. Clostridium perfringens beta-toxin is sensitive to thiol-group modification but does not require a thiol group for lethal activity. Biochim. Biophys. Acta 1999; 1454(1)97–105, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Nagahama M., Morimitsu S., Kihara A., Akita M., Setsu K., Sakurai J. Involvement of tachykinin receptors in Clostridium perfringens beta-toxin-induced plasma extravasation. Br. J. Pharmacol. 2003a; 138(1)23–30, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Nagahama M., Hayashi S., Morimitstu S., Sakurai J. Biological activities and pore-formation of Clostridium perfringens beta-toxin in HL 60 cells. J. Biol. Chem. 2003b; 278(38)36934–36941, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Pinkney M., Beachey E., Kehoe M. The thiol-activated toxin streptolysin O does not require a thiol group for cytolytic activity. Infect. Immun. 1989; 57(8)2553–2558, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Sakurai J. Toxins of Clostridium perfringens. Rev. Medical. Microbiol. 1995; 6(3)175–185, [CSA]
   Google Scholar
• Sakurai J., Duncan C. L. Purification of beta-toxin from Clostridium perfringens type C. Infect. Immun. 1977; 18(3)741–745, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Sakurai J., Duncan C. L. Some properties of beta-toxin produced by Clostridium perfringens type C. Infect. Immun. 1978; 21(2)678–680, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Sakurai J., Fujii Y., Matsuura M. Effect of oxidizing agents and sulfhydryl group reagents on beta toxin from Clostridium perfringens type C. Microbiol. Immunol. 1980; 24(7)595–601, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Sakurai J., Fujii Y., Matsuura M., Endo K. Pharmacological effect of beta toxin of Clostridium perfringens type C on rats. Microbiol. Immunol. 1981; 25(5)423–432, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Sakurai J., Fujii Y., Dezaki K., Endo K. Effect of Clostridium perfringens beta toxin on blood pressure of rats. Microbiol. Immunol. 1984; 28(1)23–31, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Sakurai J., Fujii Y. Purification and characterization of Clostridium perfringens beta toxin. Toxicon. 1987; 25(12)1301–1310, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Sakurai J., Nagahama M. Mechanism of action of Clostridium perfringens beta-toxin. Recent Res. Devel. Infect. Immun. 2003; 1: 433–449, [CSA]
   Google Scholar
• Sakurai J., Fujii Y., Nagahama M. Effect of p-chloromercuribenzoate on Clostridium perfringens beta toxin. Toxicon. 1992; 30(3)323–330, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Sakurai J., Nagahama M., Ochi S. Major toxins of Clostridium perfringens. J. Toxicol. Toxin Rev. 1997; 16(4)195–214, [CSA]
   Google Scholar
• Schraw W., Li Y., McClain M. S., van der Goot F. G., Cover T. L. Association of Helicobacter pylori Vacuolating Toxin (VacA) with Lipid Rafts. J. Biol. Chem. 2002; 277(37)34642–34650, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Sekino-Suzuki N., Nakamura M., Mitsui K., Ohno-Iwashita Y. Contribution of individual tryptophan residues to the structure and activity of θ-toxin (perfringolysin O), a cholesterol-binding cytolysin. Eur. J. Biochem. 1996; 241(3)941–947, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Shatursky O., Bayles R., Rogers M., Jost B. H., Songer J. G., Tweten R. K. Clostridium perfringens beta-toxin forms potential-dependent, cation-selective channels in lipid bilayers. Infect. Immun. 2000; 68(10)5546–5551, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000; 1(1)31–39, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Siney L., Brain S. D. Involvement of sensory neuropeptides in the development of plasma extravasation in rat dorsal skin following thermal injury. Br. J. Pharmacol. 1996; 117(6)1065–1070, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Song L., Hobaugh M. R., Shustak C., Cheley S., Bayley H., Gouaux J. E. Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 1996; 274(5294)1859–1866, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Songer J. G. Clostridial enteric diseases of domestic animals. Clin. Microbiol. Rev. 1996; 9(2)216–234, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Steinthorsdottir V., Fridriksdottir V., Gunnarsson E., Andresson O. S. Site-directed mutagenesis of Clostridium perfringens beta-toxin: expression of wild-type and mutant toxins in Bacillus subtilis. FEMS Microbiol. Lett. 1998; 158(1)17–23, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Steinthorsdottir V., Halldorsson H., Andresson O. S. Clostridium perfringens beta-toxin forms multimeric transmembrane pores in human endothelial cells. Microb. Pathog. 2000; 28(1)45–50, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Waheed A. A., Shimada Y., Heijnen H. F., Nakamura M., Inomata M., Hayashi M., Iwashita S., Slot J. W., Ohno-Iwashita Y. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts). Proc. Natl. Acad. Sci. USA 2001; 98(9)4926–4931, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Walker B., Bayley H. Key residues for membrane binding, oligomerization, and pore forming activity of staphylococcal alpha-hemolysin identified by cysteine scanning mutagenesis and targeted chemical modification. J. Biol. Chem. 1995; 270(39)23065–23071, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ziessler J., Rassfeld-Sternberg L. Enteritis necroticans due to Clostridium welchi type F. Br. Med. J. 1949; 1: 267, [CSA]
   Google Scholar